Drug recall · May 17, 2023
Gabapentin Tablets recall
Why: Product mixup: one foreign tablet found in product.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Gabapentin Tablets, USP 600 mg, packaged in Cartons of 100 tablets (10 tablets per blister pack x 10), Rx Only, Distributed by: Aurobindo Pharma USA, Inc. East Windsor, NJ 08520 Distributed by: Major Pharmaceuticals 17177 N Laurel Park Dr., Suite 233 Livonia, MI 48152 USA, NDC 0904-6823-61
- Lots / codes
Lot: T04468, Exp 10/2024
- Quantity
- 3984 cartons
- Company
- The Harvard Drug Group, La Vergne, TN
- Distribution
- USA Nationwide
- Initiated
- April 24, 2023 · Voluntary: Firm initiated
- Classified
- May 10, 2023
- Reported
- May 17, 2023
- Ended
- April 30, 2024
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Gabapentin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.